Skip to content

Clinical Study of Decalcification Bone Scaffold for Cartilage Lesions of the Knee

Clinical Study of Decalcification Bone Scaffold for Cartilage Lesions of the Knee

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03321812
Enrollment
60
Registered
2017-10-26
Start date
2018-09-11
Completion date
2023-12-30
Last updated
2020-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cartilage Injury

Keywords

decalcification bone scaffold, microfracture, randomized controlled trial, cartilage lesions of the knee

Brief summary

The trial evaluates the clinical efficacy and safety of decalcification bone scaffold for cartilage lesions of the knee. Half of participants will receive decalcification bone scaffold combined with microfracture, while the other will only receive microfracture as a control group.

Detailed description

Decalcification bone scaffold is a tissue engineering scaffold with the closest biomechanics and structure of normal cartilage. The objective of the study is to evaluate the clinical efficacy of arthroscopic decalcification bone scaffold combined with microfracture in the repairment of articular cartilage defects by randomized controlled trial. Sixty patients with clinically diagnosed knee cartilage injury according to 1: 1 were divided into experimental group and control group. The experimental group will be treated with decalcification bone scaffold combined with microfracture .The control group will be treated with microfracture . The patients will be treated by the same surgeon in this study group. MRI evaluation, Lysholm score, IKDC score, Tegner score, VAS score are selected as the measures of outcome, while the blood routine, blood biochemistry, urine, CRP, ECG and other laboratory tests will be recorded inclduing the incidence of adverse events.

Interventions

PROCEDUREdecalcification bone scaffold

Decalcification bone scaffold is a tissue engineering acellular matrix scaffold with the closest biomechanics and structure of normal cartilage.

PROCEDUREmicrofracture

Microfracture is the surgical option for conventional treatment of cartilage defects.

Sponsors

Peking University Third Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* 18-50 years old, male or female * Cartilage defect 2-8 cm² * Subjects have the surgical indication of microfracture and no contradiction * Subjects participate the clinical trial voluntarily, and sign informed consent * Subjects could comply with follow-up

Exclusion criteria

* Participated in other drug or medical device clinical trials in the last 6 months. * Can not accept allogeneic decalcified bone due to religion, ethnic and other issues. * Defect area 2 cm² or 8 cm² or lack of normal cartilage tissue around defect zone. * Complex multi-ligament injury * Suffered from systemic immune disease or systemic, locally infected * Joint fibrosis, joint rigidity, mobility was significantly limited * Moderate and severe osteoarthritis * With contraindications to MRI * Hemophilia * General condition can not tolerate surgery * Pregnant or planned pregnant women and lactating women * With abnormal spirit and selfless ability * Other circumstances judged by doctors that can not participate in the trial

Design outcomes

Primary

MeasureTime frameDescription
Appraise of magnetic reasonance imaging5 yearsEvaluate the articular cartilage postoperatively by MRI.

Secondary

MeasureTime frameDescription
Lysholm score5 yearsThe Lysholm score consists of eight items including limping, locking, pain, stair climbing, use of supports, instability, swelling, and squatting. The higher values represent a better outcome.
International Knee Documentation Committee (IKDC) 20005 yearsInternational Knee Documentation Committee (IKDC) 2000. The higher values represent a better outcome.
Tegner activity level score5 yearsThe highest level of activity that you participated in before your injury and the highest level you are able to participate in currently. The higher values represent a better outcome.
Visual analogue scale5 yearsThe visual analogue scale or visual analog scale (VAS) is a psychometric response scale which can be used in questionnaires. It is a measurement instrument for subjective characteristics or attitudes that cannot be directly measured. When responding to a VAS item, respondents specify their level of agreement to a statement by indicating a position along a continuous line between two end-points. From 0 to 10, no pain 0, worst pain imaginable 10. The higher values represent a worse outcome.

Countries

China

Contacts

Primary ContactXiaoqing Hu, phd
aoyingfang@163.com+8613401096777

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026